Daniele Ouellet, PhD, is Vice-President and Global Head of Pharmacometrics at Pfizer, where her focus is to apply model informed drug development (MIDD) principles to the portfolio. In her current role, Daniele is responsible for a group of Pharmacometricians who provide MIDD input to projects, hands on modeling and simulation expertise, model-based-meta-analyses, non-compartmental analyses and ensure efficient delivery of pharmacometric analyses and reporting. Daniele has been working in the pharmaceutical industry for > 25 years and published > 50 original articles. Daniele has a BPharm degree, University of Montreal, and a MS and PhD from the University of North Carolina at Chapel Hill.